We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
-2.6%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$9.68B
AUM Growth
-$563M
Cap. Flow
-$165M
Cap. Flow %
-1.7%
Top 10 Hldgs %
52.24%
Holding
834
New
152
Increased
118
Reduced
346
Closed
218

Sector Composition

Rank Sector Weight
1 Energy 67.04%
2 Financials 2.89%
3 Materials 2.22%
4 Healthcare 2.17%
5 Technology 1.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OMED
576
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$342K ﹤0.01%
33,861
-5,802
-15% -$68.1K
NDRM
577
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
$342K ﹤0.01%
24,220
-4,152
-15% -$56.1K
TRGP icon
578
Targa Resources
TRGP
$60.4B
$337K ﹤0.01%
11,295
-36,394
-76% -$868K
IMDZ
579
DELISTED
Immune Design Corp.
IMDZ
$294K ﹤0.01%
22,653
-3,881
-15% -$44.8K
SAND
580
DELISTED
Sandstorm Gold
SAND
$286K ﹤0.01%
86,903
-900,518
-91% -$2.48M
AGTC
581
DELISTED
Applied Genetic Technologies Corporation
AGTC
$284K ﹤0.01%
20,285
-3,432
-14% -$50.3K
ET icon
582
Energy Transfer Partners
ET
$70.1B
$280K ﹤0.01%
39,331
-171,145
-81% -$1.34M
PAGP icon
583
Plains GP Holdings
PAGP
$5.23B
$270K ﹤0.01%
11,680
-72,698
-86% -$1.49M
OCUL icon
584
Ocular Therapeutix
OCUL
$1.86B
$269K ﹤0.01%
27,816
-4,767
-15% -$36.1K
CMRX
585
DELISTED
Chimerix, Inc.
CMRX
$265K ﹤0.01%
51,896
-8,895
-15% -$58.1K
ARAV
586
DELISTED
Aravive, Inc. Common Stock
ARAV
$265K ﹤0.01%
5,503
-943
-15% -$50K
ARLZ
587
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$255K ﹤0.01%
+71,930
New +$371K
PTCT icon
588
PTC Therapeutics
PTCT
$6.37B
$248K ﹤0.01%
38,541
-6,606
-15% -$115K
CHMA
589
DELISTED
Chiasma, Inc. Common Stock
CHMA
$247K ﹤0.01%
26,920
-4,614
-15% -$49.9K
GNCA
590
DELISTED
Genocea Biosciences, Inc.
GNCA
$245K ﹤0.01%
3,958
-672
-15% -$21.3K
VIV icon
591
Telefônica Brasil
VIV
$22.4B
$235K ﹤0.01%
18,785
+685
+4% +$6.67K
MBT
592
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
$235K ﹤0.01%
29,063
+2,266
+8% +$15.8K
BCRX icon
593
BioCryst Pharmaceuticals
BCRX
$2.37B
$233K ﹤0.01%
82,476
-14,134
-15% -$62.6K
SRRA
594
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$228K ﹤0.01%
845
-145
-15% -$46.3K
INFY icon
595
Infosys
INFY
$45B
$227K ﹤0.01%
23,882
+2,798
+13% +$24.4K
CBD
596
DELISTED
Companhia Brasileira de Distribuicao
CBD
$227K ﹤0.01%
16,295
+2,295
+16% +$25K
FOMX
597
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$224K ﹤0.01%
34,363
-5,890
-15% -$38K
FLXN
598
DELISTED
Flexion Therapeutics, Inc.
FLXN
$223K ﹤0.01%
24,223
-4,151
-15% -$50.3K
OSIR
599
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
$221K ﹤0.01%
38,746
-6,641
-15% -$46.4K
RCKT icon
600
Rocket Pharmaceuticals
RCKT
$348M
$220K ﹤0.01%
7,425
-1,273
-15% -$38.2K

Similar funds

ALPS Advisors's Q1 2016 Portfolio in Review

As of Q1 2016, ALPS Advisors held 834 positions worth $9.68B, down 5.5% from $10.2B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

ALPS Advisors's Q1 2016 filing shows 152 new, 118 increased, 346 reduced and 218 closed positions. Its largest new stake was ANTERO MIDSTREAM PARTNERS LP: 3,928,591 shares worth $86.9M. The largest sale was TARGA RESOURCES PARTNERS LP COM UTS REPTG LTD PARTERSHIP INT, an estimated $215M.

By sector, the portfolio is most concentrated in Energy at 67% of assets, down from 68% a quarter earlier, followed by Financials and Materials.

  • ALPS Advisors's largest Q1 2016 buy was ANTERO MIDSTREAM PARTNERS LP: 3,928,591 shares worth $86.9M.
  • ALPS Advisors added most to Energy Transfer Partners L.p. in Q1 2016, an estimated $275M increase.
  • ALPS Advisors's biggest Q1 2016 reduction was Oneok Partners LP, cutting an estimated $50.8M.
  • ALPS Advisors fully exited TARGA RESOURCES PARTNERS LP COM UTS REPTG LTD PARTERSHIP INT in Q1 2016, selling an estimated $215M.
  • ALPS Advisors's ten largest holdings make up 52% of its $9.68B portfolio in Q1 2016.
  • ALPS Advisors opened 152 new positions and closed 218 in Q1 2016.
  • ALPS Advisors's portfolio value fell 5.5% quarter-over-quarter to $9.68B.

Based on ALPS Advisors's 13F filing for Q1 2016, filed 10 May 2016.